Cetera Advisor Networks LLC Organon & Co. Transaction History

Cetera Advisor Networks LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.78 - $18.8 $15,130 - $20,642	1,098 Added 3.48%	32,665 $614,000
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $15,647 - $24,750	1,429 Added 4.74%	31,567 $455,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $54,647 - $78,298	3,294 Added 12.27%	30,138 $523,000
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $53,801 - $68,766	2,792 Added 11.61%	26,844 $558,000
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $77,797 - $116,514	3,632 Added 17.79%	24,052 $565,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $41,794 - $51,297	1,793 Added 9.63%	20,420 $570,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $129,565 - $189,642	-5,537 Reduced 22.91%	18,627 $436,000
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $37,422 - $45,979	1,182 Added 5.14%	24,164 $815,000
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $62,087 - $80,255	2,039 Added 9.74%	22,982 $803,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $56,537 - $73,220	1,972 Added 10.39%	20,943 $638,000
Q3 2021 Nov 16, 2021	SELL	$28.63 - $35.64 $40,654 - $50,608	-1,420 Reduced 6.96%	18,971 $622,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $580,123 - $774,858	20,391 New	20,391 $617,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.